-- Program supports BioEclipse's study of CRX100 in patients with advanced solid tumors-- Grant is part of CIRM fundsupporting clinical-stage candidate stem cell treatments that demonstrate scientific excellence
MOUNTAIN VIEW, Calif., April 26, 2022 /PRNewswire/ --BioEclipse Therapeutics, Inc (BioEclipse), a privately held, clinical-stage biopharmaceutical company with a proprietary platform for developing next-generation cancer immunotherapies, announcedtoday it has been awarded a $7,999,689.00 grant by the California Institute for Regenerative Medicine (CIRM) to support its ongoing clinical study: A Phase 1, open-label, dose-escalation study of CRX100 in patients with advanced solid tumors.
BioEclipse is performing a Phase 1 clinical study evaluating the safety and tolerability of CRX100, a first-in-class immunotherapy that pairs the power of an oncolytic virus with the tumor-locating ability of cytokine-induced killer (CIK) cells. These immune cells naturally locate and destroy cancer cells and when combined with our oncolytic virus create a powerful cancer immunotherapy to treat patients who are resistant to standard of care treatments and have recurring disease.
BioEclipse President and CEO Pamela Reilly Contag, Ph.D. and Principal Investigator of the grant, said, "We believe the best way to cure cancer is by developing new, multi-mechanistic therapies that are safe, effective, and accessible to diverse populations. Our technology harnesses two distinct methods of actionusing immune cells loaded with a cancer-killing virus that targets cancer tissue but spares healthy tissue. Immunotherapies such as CRX100 are an extremely powerful approach to give oncologists another tool to improve outcomes, while giving the body tools to fight a relapse and recurrence. We extend our sincerest appreciation to CIRM. Their support has validated our technology and expertise, and we welcome opportunities with partners and investors moving forward as we work towards achieving our goals."
Oliver Dorigo, M.D., Ph.D., Principal Investigator of the clinical trial and Director of the Gynecologic Cancer Service at Stanford University, said, "CRX100addresses a significant unmet medical need in fatal conditions for which there are limited treatment options. CRX100, which migrates to the tumor site, targets tumor cells and delivers the cancer-destroying virus, has the potential to significantly help those with chemotherapy-resistant or refractory solid tumorsincluding colorectal cancer, triple-negative breast cancer, ovarian cancer, gastric cancer, hepatocellular carcinoma, and osteosarcoma." The trial locations also include HonorHealth Research Institute in Scottsdale, Arizona, and UC San Diego Moores Cancer Center in La Jolla, California.
About BioEclipse TherapeuticsBioEclipse Therapeutics is an emerging, clinical-stage biopharmaceutical company using a novel platform that combines immune cells and an oncolytic virus to expand treatment options for patients with refractory solid tumors. Our focus is currentlyon the treatment of recurringcancers with our unique multi-mechanistic approach that could address cancers believed to be untreatable. BioEclipse Therapeutics has started a Phase 1 clinical trial with CRX100, a patented, first-in-class, intravenously delivered, targeted immunotherapy against solid tumors. CRX100 is being developed to deliver potentially curative treatment to patients over a broad range of tumor types, including some rare pediatric cancers.For more information, visitwww.bioeclipse.com. For more information on the trial see https://www.clinicaltrials.gov/ct2/show/NCT04282044.
Contacts:Tiberend Strategic Advisors, Inc.Bill Bordenbborden@tiberend.com
Rosalyn Christianrchristian@tiberend.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/bioeclipse-therapeutics-awarded-almost-8-million-grant-by-california-institute-for-regenerative-medicine-cirm-to-fund-ongoing-phase-1-crx100-cancer-immunotherapy-clinical-trial-301532795.html
SOURCE BioEclipse Therapeutics
- Arizona Oncology Cancer Center working with NexCore Group on new cancer treatment center - Yahoo Finance - October 13th, 2022
- Senate Passes 'Inflation Reduction Act' Which Will Likely Make Inflation Worse - Reason - August 14th, 2022
- Reds prospect rankings will shift after trade deadline acquisition of 10 players - The Athletic - August 5th, 2022
- Stem Cell Therapy Pros and Cons - Arizona Pain and Spine Institute - July 11th, 2022
- Bone Anatomy | Ask A Biologist - Arizona State University - July 11th, 2022
- No, "Top Gun" isn't an anti-woke success story, but rather a tribute to aging Tom Cruise and balls - Salon - June 4th, 2022
- Maine health care workers to appeal order to disclose their names in vaccine mandate lawsuit - Lewiston Sun Journal - June 4th, 2022
- Right to Try 2.0: Ahwatukee family pushes for proposed law after getting medical treatment abroad - FOX 10 News Phoenix - April 6th, 2022
- Inside the real life Noahs Ark designed to save mankind after the apocalypse with a back up vault on t... - The US Sun - January 5th, 2022
- Human Embryonic Stem Cells - Arizona State University - November 22nd, 2021
- Mindy Kaling's 'The Sex Lives of College Girls' Is a Spot-On Depiction of College - Glamour - November 22nd, 2021
- Bridging the gap between online and on campus - ASU Now - November 22nd, 2021
- Bacterial Infections Linked with Unapproved Stem Cell Treatments - Contagionlive.com - October 28th, 2021
- ASU professor researches origins of Alzheimers to find a cure - Eight, Arizona PBS - October 16th, 2021
- City of Hope to Accelerate Blood Cancer Research Through a Transformational Gift from Leukemia Survivor James Belardi and His Wife Leslie Belardi -... - October 5th, 2021
- Calidi Biotherapeutics Announces Exclusive License Agreement with City of Hope and the University of Chicago for Novel Oncolytic Virotherapy... - August 18th, 2021
- Jim McMahon broke his neck playing for Vikings, and found out about it 17 years later - TwinCities.com-Pioneer Press - December 23rd, 2020
- Want to Know Where The Best Fall Colors Are in Your Area? Check Out This Interactive US Map - Good News Network - October 5th, 2020
- 'Were not your slaves': Alternative health providers bristle at warning letters about their coronavirus treatments - USA TODAY - September 4th, 2020
- Neogene precipitation, vegetation, and elevation history of the Central Andean Plateau - Science Advances - September 4th, 2020
- Research Roundup: Lasting Immunity to COVID-19 and More - BioSpace - August 21st, 2020
- What in the world is 'Project Carpaccio' and which Israeli company is doing business in Abu Dhabi? - CTech - August 21st, 2020
- Viruses have big impacts on ecology and evolution as well as human health - The Economist - August 21st, 2020
- Encouraging News About Coronavirus Immunity | In the Pipeline - Science Magazine - August 21st, 2020
- Scientists are seeing signs of lasting immunity to COVID-19, among survivors with even mild infections - Firstpost - August 21st, 2020
- Studies show positive signs of strong, lasting Covid-19 immunity - The Irish Times - August 21st, 2020
- Coronavirus vaccine will take time, so researchers are hunting for and finding promising new COVID-19 tre - OregonLive - April 6th, 2020
- Penn announces seven 2020 Thouron Award winners - Penn: Office of University Communications - February 24th, 2020
- Unlocking The Secrets Of DNA Help Researchers Understand How to Slow Aging - YouAreUNLTD - January 9th, 2020
- An ESPN reporter was diagnosed with HLH just before he died at age 34. What is it? - ABC15 Arizona - January 2nd, 2020
- 2020s visions: We'll get flying cars just before becoming software-based people - CNET - December 19th, 2019
- Man fights $4,600 surgery bill he was told insurance would cover - KGUN - December 8th, 2019
- Professor Recognized For Cardiac Regeneration Research - WPI News - December 8th, 2019
- Creative Medical Technology Holdings, Inc. Discusses CaverStem and Other Patented Technology with The Stock Day Podcast - Yahoo Finance - October 19th, 2019
- Bone marrow recipient comes face-to-face with CT donor for the first time - WTNH.com - October 19th, 2019
- Positive Study Results of Phase IIa Clinical Trial Using Intravenous Administration of Mesenchymal Stem Cells for Ischemic Stroke Published in... - October 1st, 2019
- Stem Cell Education Center - Stem Cell Treatment | Arizona ... - September 14th, 2019
- Stem Cell Therapy In Scottsdale Arizona | Regenerative ... - September 12th, 2019
- Stem Cell Therapy | Board Certified Orthopedic Surgeon ... - March 16th, 2019
- Stem Cell Lake Havasu City Arizona 86406 - March 8th, 2019
- Stem Cell Therapy for Cancer | Arizona Pain and Spine ... - December 18th, 2018
- Stem Cells | Arizona Pain Specialists - Scottsdale ... - December 11th, 2018
- Arizona Pain Regenerative Institute - Arizona Pain Specialists - December 5th, 2018
- Stem Cell Therapy Phoenix Arizona | Desert Health Specialists - December 4th, 2018
- Southwest Spine and Sports - Pain Management Doctor Arizona - September 24th, 2018
- Celebration Stem Cell Centre - A private umbilical cord ... - August 12th, 2018
- Bone marrow transplant - Mayo Clinic - July 15th, 2018
- About Dr. Nabil Dib - June 27th, 2018
- Around the world - Bend Bulletin - August 30th, 2017
- FDA Cracks Down On Stem-Cell Clinics Selling Unapproved Treatments - KNAU Arizona Public Radio - August 30th, 2017
- BrainStorm Supports Commitment to ALS Patient Community with ... - Markets Insider - August 8th, 2017
- ASU grad students' lab skills help earn funding for cutting-edge biomedical research - Arizona State University - August 8th, 2017
- Will putting leeches on his face help this blind man see? - USA TODAY - August 8th, 2017
- Engineered Skin Cells Control Type 2 Diabetes in Mice: Study ... - Arizona Daily Star - August 8th, 2017
- 'Soft' side of bioengineering poised to make big impacts - Arizona State University - August 4th, 2017
- Tackling hard-to-treat cancers from every angle - Medical Xpress - June 21st, 2017
- ALS Research Forum | To Evaluate Stem Cell Therapies, Think ... - ALS Research Forum - June 20th, 2017
- New book by ASU researcher explores cancer's pervasive mysteries - Arizona State University - June 18th, 2017
- Arizona Supreme Court Clears Way For Adoption of American Indian Child by Non-Native Parents - Reason (blog) - June 15th, 2017
- Can We Cheat Death? US Firm Aims To Resurrect Brain-Dead People Using Stem Cells - International Business Times - June 11th, 2017
- The three cancers Jews need to worry about most and how to reduce the risks - Jewish Post - June 11th, 2017
- Patient-Centered Stem Cell Therapy Bill Passed by Texas Legislature - satPRnews (press release) - May 31st, 2017
- 6 Arizona young women are taking on the STEM gender gap - AZCentral.com - May 28th, 2017
- Scientists wary as Texas mulls allowing sale of unproven drugs - Texas Tribune - May 26th, 2017
- Scientists wary as Texas mulls allowing sale of unproven drugs - Bryan-College Station Eagle - May 24th, 2017
- ASU engineers envision 'guiding' body's cells to help improve health - Arizona State University - May 19th, 2017
- GV Gardeners: Sun-loving saguaro Southwest symbol | Sun Life ... - Sahuarita Sun (subscription) - May 19th, 2017
- Derek McCartney Named To Lott IMPACT Trophy Watch List - KKTV 11 News - May 18th, 2017
- Tucson Tech: University of Arizona startup advances living heart patch - Arizona Daily Star - May 15th, 2017
- Scientists uncover root of graying, thinning hair - Arizona Daily Star - May 15th, 2017
- GV Gardeners: Sun-loving saguaro Southwest symbol - Green Valley News - May 15th, 2017
- 7-year-old Hollis spread joy around U.S. After losing him to rare brain tumor, parents turn to finding cure - AZCentral.com - May 1st, 2017
- Young minds meet new technology at STEM-focused after-school program - USC News - April 19th, 2017
- Applications for Tissue Culture in Cannabis Growing: Part 1 - Cannabis Industry Journal (blog) - April 14th, 2017
- Yankees: James Kaprielian Getting Tommy John Surgery Out of the Way - Yanks Go Yard - April 14th, 2017
- Can Stem Cell 'Patch' Help Heart Failure? - Arizona Daily Star - April 9th, 2017
- Angels' focus is on defense - Reading Eagle - April 2nd, 2017
- Some restoration drama at the Big A as Dodgers top Angels, 3-1 - Los Angeles Times - April 1st, 2017
- Robert Clayton Robbins Top Choice for UA President - Arizona Public Media - March 10th, 2017
- R. William Funk Lands New Leader for University of Arizona - Hunt Scanlon Media (press release) - March 9th, 2017